Aldeyra Therapeutics, Inc. (ALDX): Shares Outstanding

Annual figures by period end, from SEC filings.

60.16M
As of 2025-12-31
60.32M
As of 2026-06-30
+0.9%
3-year compound annual growth
2014-12-31: 5.57M2015-12-31: 9.71M2016-12-31: 12.58M2017-12-31: 19.14M2018-12-31: 26.24M2019-12-31: 28.66M2020-12-31: 38.67M2021-12-31: 58.08M2022-12-31: 58.56M2023-12-31: 59.20M2024-12-31: 59.65M2025-12-31: 60.16M60.16M
2014-12-31 Shares Outstanding (shares) 2025-12-31
Period endedShares OutstandingChange YoYSource filing
2025-12-3160.16M+0.9%2026-02-27, Balance as of period end
2024-12-3159.65M+0.8%2026-02-27, Balance as of period end
2023-12-3159.20M+1.1%2025-02-28, Balance as of period end
2022-12-3158.56M+0.8%2024-03-07, Balance as of period end
2021-12-3158.08Mn/c2023-03-09, Balance as of period end
2020-12-3138.67M+34.9%2022-03-17, Balance as of period end
2019-12-3128.66M+9.2%2021-03-11, Balance as of period end
2018-12-3126.24M+37.1%2020-03-12, Balance as of period end
2017-12-3119.14Mn/c2019-03-08, Balance as of period end
2016-12-3112.58M+29.5%2018-03-29, Balance as of period end
2015-12-319.71M+74.5%2017-03-30, Balance as of period end
2014-12-315.57Mn/a2016-03-30, Balance as of period end